Private-equity firm KKR has agreed to sell its entire 46% stake in India-listed J.B. Chemicals & Pharmaceuticals to Torrent Pharmaceuticals for $1.4 billion. Following this, the two pharmaceutical firms will merge. According to KKR, the Rationale for the Acquisition are: Access to Fast-Growing India Franchise: The acquisition grants Torrent Pharma...